Advertisement

Index by author

September 01, 1994; Volume 22,Issue 5

A

  1. Amann, M T

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

B

  1. Bai, S A

    1. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
      S M Lankford, C Maskasame and S A Bai
      Drug Metabolism and Disposition September 1994, 22 (5) 776-787;

  2. Baker, G B

    1. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;

  3. Bolaji, O O

    1. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;

  4. Burcham, D L

    1. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

  5. Buters, J T

    1. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

C

  1. Cepa, S P

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  2. Chang, T K

    1. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
      T K Chang, H Chen and D J Waxman
      Drug Metabolism and Disposition September 1994, 22 (5) 673-679;

  3. Charkowski, D M

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  4. Charman, W N

    1. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
      N L Pochopin, W N Charman and V J Stella
      Drug Metabolism and Disposition September 1994, 22 (5) 770-775;

  5. Chen, H

    1. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
      T K Chang, H Chen and D J Waxman
      Drug Metabolism and Disposition September 1994, 22 (5) 673-679;

  6. Chen, I W

    1. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
      I W Chen and J H Lin
      Drug Metabolism and Disposition September 1994, 22 (5) 693-699;

  7. Chiu, S H

    1. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

  8. Coffman, B

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  9. Coutts, R T

    1. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;

D

  1. Dekant, W

    1. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;

  2. Dow, J

    1. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;

  3. Dulery, B D

    1. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;

F

  1. Ferrero, J L

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  2. Fujimaki, M

    1. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
      M Fujimaki
      Drug Metabolism and Disposition September 1994, 22 (5) 700-708;

G

  1. Gal, J

    1. Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;

  2. Garvey, D S

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  3. Gescher, A

    1. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;

  4. Gonzalez, F J

    1. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

  5. Goto, M

    1. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;

  6. Green, M D

    1. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
      M D Green, E M Oturu and T R Tephly
      Drug Metabolism and Disposition September 1994, 22 (5) 799-805;

  7. Gregus, Z

    1. Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

  8. Grubb, M F

    1. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

  9. Guenthner, T M

    1. Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1994, 22 (5) 731-737;

H

  1. Haegele, K D

    1. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;

  2. Hardwick, J P

    1. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

  3. Hargreaves, M B

    1. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;

  4. Hashizaki, M

    1. Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;

  5. Hijioka, T

    1. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;

  6. Hirobe, M

    1. Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;

  7. Hooper, W D

    1. Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;

  8. Huang, S M

    1. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

J

  1. Jones, B C

    1. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;

K

  1. Karanam, B V

    1. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

  2. Kato, H

    1. Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;

  3. Kauffman, F C

    1. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;

  4. Kawazoe, S

    1. Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
      T Mizutani, K Yoshida and S Kawazoe
      Drug Metabolism and Disposition September 1994, 22 (5) 750-755;

  5. Kerssebaum, R

    1. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;

  6. Kim, H J

    1. Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

  7. Klaassen, C D

    1. Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

  8. Korzekwa, K R

    1. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

  9. Köster, U

    1. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;

  10. Kunze, K L

    1. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

L

  1. Lankford, S M

    1. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
      S M Lankford, C Maskasame and S A Bai
      Drug Metabolism and Disposition September 1994, 22 (5) 776-787;

  2. Lin, J H

    1. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
      I W Chen and J H Lin
      Drug Metabolism and Disposition September 1994, 22 (5) 693-699;

  3. Liu, Y

    1. Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

  4. Luo, G

    1. Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
      G Luo and T M Guenthner
      Drug Metabolism and Disposition September 1994, 22 (5) 731-737;

M

  1. Machinist, J M

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  2. Madhu, C

    1. Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

  3. Maskasame, C

    1. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
      S M Lankford, C Maskasame and S A Bai
      Drug Metabolism and Disposition September 1994, 22 (5) 776-787;

  4. McQuade, R D

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  5. Mizutani, T

    1. Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
      T Mizutani, K Yoshida and S Kawazoe
      Drug Metabolism and Disposition September 1994, 22 (5) 750-755;
    2. Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;

N

  1. Nagata, O

    1. Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;

  2. Newton, D J

    1. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

O

  1. Ohta, S

    1. Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;

  2. Oide, H

    1. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;

  3. Omata, Y

    1. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
      J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J Gonzalez
      Drug Metabolism and Disposition September 1994, 22 (5) 688-692;

  4. Oturu, E M

    1. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
      M D Green, E M Oturu and T R Tephly
      Drug Metabolism and Disposition September 1994, 22 (5) 799-805;

P

  1. Piriou, F

    1. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;

  2. Pochopin, N L

    1. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
      N L Pochopin, W N Charman and V J Stella
      Drug Metabolism and Disposition September 1994, 22 (5) 770-775;

  3. Pool, W F

    1. Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;

Q

  1. Quon, C Y

    1. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

R

  1. Rios, G

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  2. Rodrigues, A D

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  3. Rotert, G A

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  4. Rozman, P

    1. Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.
      Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D Klaassen
      Drug Metabolism and Disposition September 1994, 22 (5) 725-730;

S

  1. Saxton, P L

    1. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

  2. Smith, D A

    1. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
      M B Hargreaves, B C Jones, D A Smith and A Gescher
      Drug Metabolism and Disposition September 1994, 22 (5) 806-810;

  3. Speerschneider, P

    1. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;

  4. Stella, V J

    1. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
      N L Pochopin, W N Charman and V J Stella
      Drug Metabolism and Disposition September 1994, 22 (5) 770-775;

  5. Styczynski, P

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  6. Su, P

    1. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
      R T Coutts, O O Bolaji, P Su and G B Baker
      Drug Metabolism and Disposition September 1994, 22 (5) 756-760;

  7. Sullivan, J P

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

  8. Surber, B W

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

T

  1. Tajima, K

    1. Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;

  2. Takahara, E

    1. Inter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.
      E Takahara, O Nagata, H Kato, S Ohta and M Hirobe
      Drug Metabolism and Disposition September 1994, 22 (5) 761-769;

  3. Tedford, C E

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  4. Tephly, T R

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;
    2. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
      M D Green, E M Oturu and T R Tephly
      Drug Metabolism and Disposition September 1994, 22 (5) 799-805;

  5. Thurman, R G

    1. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;

  6. Tich, N R

    1. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
      A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S Garvey
      Drug Metabolism and Disposition September 1994, 22 (5) 788-798;

V

  1. Vanrollins, M

    1. Studies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.
      T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E Tedford
      Drug Metabolism and Disposition September 1994, 22 (5) 713-718;

  2. Vincent, S H

    1. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

W

  1. Wang, R W

    1. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.
      B V Karanam, S H Vincent, D J Newton, R W Wang and S H Chiu
      Drug Metabolism and Disposition September 1994, 22 (5) 811-814;

  2. Waxman, D J

    1. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
      T K Chang, H Chen and D J Waxman
      Drug Metabolism and Disposition September 1994, 22 (5) 673-679;

  3. Wittmann, H

    1. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
      U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W Dekant
      Drug Metabolism and Disposition September 1994, 22 (5) 667-672;

  4. Wolf, E

    1. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
      J Dow, F Piriou, E Wolf, B D Dulery and K D Haegele
      Drug Metabolism and Disposition September 1994, 22 (5) 738-749;

  5. Wong, Y N

    1. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
      M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M Huang
      Drug Metabolism and Disposition September 1994, 22 (5) 709-712;

  6. Woolf, T F

    1. Stereoselective hydroxylation of tacrine in rats and humans.
      W D Hooper, W F Pool, T F Woolf and J Gal
      Drug Metabolism and Disposition September 1994, 22 (5) 719-724;

Y

  1. Yamamoto, K

    1. Carbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.
      K Tajima, M Hashizaki, K Yamamoto and T Mizutani
      Drug Metabolism and Disposition September 1994, 22 (5) 815-818;

  2. Yoshida, K

    1. Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
      T Mizutani, K Yoshida and S Kawazoe
      Drug Metabolism and Disposition September 1994, 22 (5) 750-755;

Z

  1. Zhong, Z

    1. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
      Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G Thurman
      Drug Metabolism and Disposition September 1994, 22 (5) 680-687;
Back to top

In this issue

Advertisement